"Crohn's Disease: Key Hopes And Understandings"
Bruce Sands, MD, MS, Burill B. Crohn professor of medicine and chief of the Dr. Henry D. Janowitza division of gastroenterology at the Icahn School of Medicine at Mount Sinai said, "My hope for the future is that we're going to be able to identify the right drug for the right patient at the right time and having more options for treatment will eventually allow us to do that. Predictive biomarkers will allow us to choose the right drug for the right patient." He added that "the availability of therapeutic drug monitoring, particularly for biologic therapies, will help fine tune treatment." The year 2032 will be the 100th anniversary of the discovery of Crohn's disease. "The field is very exciting, and there a lot of parallel things happening," said Marla Dubinsky, MD, professor of pediatrics and gastroenterology at the Icahn School of Medicine at Mount Sinai. "I think we should work on ultimate strategies that get [patients] in such deep remission that we can maybe use our microbial-based therapies to keep them there. That's the exciting part of what the next 15 years will look like."
- Bruce E. Sands, MD, MS, Burrill B. Crohn Professor of Medicine, Gastroenterology, Chief, Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai
- Marla C. Dubinsky, MD, Professor, Pediatrics, Gastroenterology, Icahn School of Medicine at Mount Sinai